June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Understanding how the G90D and G90V rhodopsin mutations cause night blindness
Author Affiliations & Notes
  • Vladimir J Kefalov
    Ophthalmology, University of California Irvine, Irvine, California, United States
  • Alexander Kolesnikov
    Ophthalmology, University of California Irvine, Irvine, California, United States
  • David Salom
    Ophthalmology, University of California Irvine, Irvine, California, United States
  • Krzysztof Palczewski
    Ophthalmology, University of California Irvine, Irvine, California, United States
  • Footnotes
    Commercial Relationships   Vladimir Kefalov None; Alexander Kolesnikov None; David Salom None; Krzysztof Palczewski None
  • Footnotes
    Support  NIH Grants EY030912, EY030873 and EY009339, Research to Prevent Blindness, and Retina Research Foundation
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2600 – F0483. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vladimir J Kefalov, Alexander Kolesnikov, David Salom, Krzysztof Palczewski; Understanding how the G90D and G90V rhodopsin mutations cause night blindness. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2600 – F0483.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A wide range of blinding disorders have been associated with mutations in the rod visual pigment rhodopsin. Point mutations of Glycine 90 to Aspartate (G90D) or to Valine (G90V) have been reported to cause congenital stationary night blindness (CSNB) and retinitis pigmentosa (RP), respectively. In vitro studies have shown that the G90D/G90V mutations cause decreased stability of both chromophore-bound rhodopsin and chromophore-free opsin. This lower stability could produce persistent activation of rod photoreceptors even in darkness and interfere with normal light detection, causing CSNB or RP. However, the molecular mechanism by which these mutations cause abnormal photoreceptor function and degeneration remains controversial.

Methods : Using CRISPR/Cas9 technology, we created homozygous mutant mice with either G90D or G90V rhodopsin and performed their initial characterization. Retinal morphology was analyzed by hematoxylin and eosin staining of retinal cross-sections. Scotopic function was assessed by in vivo electroretinography (ERG). Pigment content and stability of its 11-cis-retinal Schiff base in the dark were measured by spectrophotometry of dodecyl maltoside extracts from whole mouse eyes, in the absence or presence of hydroxylamine (HA), respectively.

Results : The morphology of the retina in both G90D and G90V mutant mice was normal up to 4 months of age, with good preservation of both outer nuclear and photoreceptor layers. However, the rod maximal response (ERG a-wave) in G90V and G90D mice at 2 months was suppressed to ~70% and ~50%, respectively, compared to controls. The rod photosensitivity was also reduced to a greater degree in the G90D than in G90V mice. The amount of rhodopsin in eyes of 2-month-old G90V mice was reduced to 25% of wild type levels. However, its 11-cis-retinal chromophore was not readily accessible to HA in the dark. In contrast, the level of rhodopsin in the eyes of G90D eyes was 35% of that in controls and its chromophore was accessible to HA.

Conclusions : Our preliminary data suggest that both G90D and G90V opsins in mouse rods have reduced chromophore binding. However, unlike in wild type and G90V rhodopsin, the covalent link between chromophore and opsin in G90D rhodopsin appears unstable and susceptible to hydrolysis. We conclude that G90V and G90D mutations in rhodopsin can cause night blindness by two different mechanisms that are being investigated further.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×